Tuberculosis in European cities: Establishment of a patient monitoring system over 10 years in Paris, France

International Journal of Tuberculosis and Lung Disease

Volumn 11, Issue 9, 2007, Pages 992-998

  Farge, Dominique ^a   Porcher, R ^a   Antoun, F ^b   Fain, O ^c   Keshtmand, H ^a   Rocher, G ^d   Mallet, H P ^b   Rambeloarisoa, J ^a   Gerber, F ^a   De Castro, N ^a   Che, D ^e   Coulombier, D ^f   Zaleskis, R ^g   Herrmann, J L ^h   Dye, C ^g   Rouvier, J ⁱ   Guesnon, M S ⁱ   Muller, G ⁱ   Ayache, B ⁱ   Dhotte, P ⁱ   Jachim, M ^j   Molina, J M ^a   Bordon, P ^a   Poinsignon, Y ^a   Sereni, D ^a   Lascoux, C ^a   Florea, L ^a   Leye, Y ^a   Bergeron, A ^a   Picard, C ^a   Tazzi, A ^a   more..

^a SAINT LOUIS HOSPITAL   (France)

^b Cellule Tuberculose   (France)

^c HÔPITAL JEAN VERDIER   (France)

^d Centre Hospitalier de Carnelle

^e INSTITUT DE VEILLE SANITAIRE   (France)

^f EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

^h RAYMOND POINCARÉ HOSPITAL   (France)

ⁱ World Health Organization ^*

^j Centre Médico Chirurgical de Bligny   (France)

more..

Author keywords

Patient cohort monitoring; TB Info software; Treatment outcomes; WHO target

Indexed keywords

AMIKACIN; CAPREOMYCIN; CLARITHROMYCIN; ETHAMBUTOL; ETHIONAMIDE; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; SPARFLOXACIN; STREPTOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EUROPE; FEMALE; FOLLOW UP; FRANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; PATIENT INFORMATION; PATIENT MONITORING; PRIORITY JOURNAL; SPUTUM SMEAR; SUPERINFECTION; TREATMENT OUTCOME;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMBULATORY CARE FACILITIES; ANTITUBERCULAR AGENTS; DATABASES, FACTUAL; EMIGRANTS AND IMMIGRANTS; FEMALE; FOLLOW-UP STUDIES; HIV; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PARIS; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; SURVIVAL RATE; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 34548739609     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Raviglione M C. The TB epidemic from 1992 to 2002. Tuberculosis 2003; 83: 4-14.
2. Frieden T R, Fujiwara P I, Washko R M, Hamburg M A. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333: 229-233.
3. Grange J M, Zumla A. The global emergency of tuberculosis: what is the cause? J R Soc Health 2002; 122: 78-81.
4. Health Protection Agency. Tuberculosis cases reported, England and Wales, 1988, 1993, 1998-2005. London, UK: HPA. http://www.hpa.org.uk/infections/ topics_az/tb/epidemiology/table14.htm Accessed June 2007.
5. Van Deutekom H, Gerritsen J J, van Soolingen D, van Ameijden E J, van Embden J D, Coutinho R A. A molecular epidemiological approach to studying the transmission of tuberculosis in Amsterdam. Clin Infect Dis 1997; 25: 1071-1077.
6. Marjanovic Z, Tuppin P, Herrmann J L, Bayol G, Toledano C, Farge D. Tuberculosis with and without initial health coverage. Eur J Intern Med 2002; 13: 180-184.
7. Valin N, Antoun F, Chouaïd C, et al. Outbreak of tuberculosis in a migrants' shelter, Paris, France, 2002. Int J Tuberc Lung Dis 2005; 9: 528-533.
8. Schwoebel V, Lambregts-van Weezenbeek C S, Moro M L, et al. Standardisation of anti-tuberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J 2000; 16: 364-371.
9. World Health Organization. WHO report 2006. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2006.362. Geneva, Switzerland: WHO, 2006. http://www.who.int/tb/publications/global/report/2006/pdf/full- report_correctedversion.pdf Accessed 1 March 2007.
10. Antoun F, Mallet H P. La tuberculose à Paris en 2003: situation actuelle et contribution du service de lutte anti tuberculose. Bull Epidemiol Hebd 2005; 17-18: 70-72.
11. Antoine D, Che D. Les cas de tuberculose déclarés en France en 2005. Bull Epidemiol Hebd 2007; 11: 85-89.
12. Cailhol J, Che D, Jarlier V, Decludt B, Robert J. Incidence of tuberculous meningitis in France, 2000: a capture-recapture analysis. Int J Tuberc Lung Dis 2005; 9: 803-808.
13. Veen J, Raviglione M, Rieder H L, et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998; 12: 505-510.
14. de Colombani P, Banatvala N, Zaleskis R, Maher D, WHO Regional Office for Europe. European framework to decrease the burden of TB/HIV. Eur Respir J 2004; 24: 493-501. http://www.euro.who.int/document/e81794.pdf Accessed March 2007.
15. World Health Organization. DOTS expansion plan to stop TB in the WHO European Region 2002-2006. Copenhagen, Denmark: WHO Regional Office for Europe, 2002. http://www.euro.who.int/document/E77477.pdf Accessed March 2007.
16. Vranken P, Coulombier D, Kenyon T, et al. Use of a computerized tuberculosis register for automated conversion of case finding, sputum conversion and treatment outcome reports. Int J Tuberc Dis 2002; 6: 111-120.
17. Bayol-Honnet G, Fain O, Joly V, et al. Un logiciel informatique pour le suivi des patients sous traitement antituberculeux. Bull Epidemiol Hebd 2001; 41: 199-203.
18. Sheldon C D, King K, Cock H, Wilkinson P, Barnes N C. Notifications of tuberculosis: how many cases are never reported? Thorax 1992; 47: 1015-1018.
19. Revised international definitions in tuberculosis control. Int J Tuberc Lung Dis 2001; 5: 213-215.
20. Falzon D, Scholten J, Infuso A. Tuberculosis outcome monitoring - is it time to update European recommendations? Eurosurveillance 2006; 11: 20-25.
21. Robert J, Trystram D, Truffot-Pernot C, Jarlier V. Multidrug-resistant tuberculosis: eight years of surveillance in France. Eur Respir J 2003; 22: 833-837.
22. Arrêté du 10 février 2006 portant nomination au Comité national d'élaboration du programme de lutte contre la tuberculose. Journal Officiel de la République Française, 16 février 2006.